Nephrology Grand Rounds: Friday, October 2- 8am


Renal Cysts: Understanding and Management, presented by Dr. Andrew Shabila

Upon completion of this activity, participants will be able to:

1. Classify a cystic renal mass using the Bosniak v2019 classification system, based on defined CT/MRI thresholds for enhancement, septation, wall thickness, and nodularity.

2. Select an appropriate management strategy — imaging surveillance, percutaneous aspiration/sclerotherapy, or percutaneous thermal ablation — for a cystic renal mass based on its Bosniak classification and the patient's renal function.

3. Distinguish rare and mimicking causes of a cystic renal lesion — including renal abscess, hemorrhagic cyst, renal lymphoma, Castleman disease, and urothelial carcinoma — from a malignant cystic renal mass.


Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

The speaker, Dr. Andrew Shabila, has disclosed a relevant financial relationship with ineligible companies, Penumbra Inc and Sirtex Medical.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Session date: 
10/02/2026 - 8:30am EDT to 12/01/2026 - 10:59pm EST
  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 1.00 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.
Faculty List: 
Planner(s)

Emily Thomas

has no relevant financial relationships to disclose at this time.
Speaker(s)

Andrew Shabila, MD

has a financial relationship (Independent contractor) with Penumbra Inc;.
has a financial relationship (Professional Services) with Sirtex Medical;.